Full Year 2024 Detection Technology Oyj Earnings Call Transcript
Key Points
- Detection Technology PLC (OHEL:DETEC) reported a slight increase in sales, reaching EUR31.6 million in the fourth quarter, marking a 1% increase from the previous year.
- The company achieved a notable improvement in EBITA, reaching EUR5.2 million, which is a clear increase from the previous year, with an EBITA margin of 16.3%.
- Security sales increased by 5%, driven by computed tomography outside of China and growth in cargo-related sales.
- The company reported a strong cash flow of EUR6.9 million in the fourth quarter and EUR20.1 million for the full year.
- Detection Technology PLC (OHEL:DETEC) plans to ramp up production at its new India factory, targeting production in the first half of the year, which could enhance its manufacturing capabilities.
- Medical sales declined by 5% due to challenges in the China market, including healthcare reform and anti-corruption campaigns.
- The Americas region experienced a significant sales decline, down close to 60%, attributed to one-time reasons such as customer inventory adjustments.
- The company faces intense price competition in China, particularly in the industrial segment, impacting sales and profitability.
- The first quarter of the upcoming year is expected to be flat, with security sales anticipated to decline due to inventory adjustments and market conditions.
- Tariff uncertainties, particularly potential new tariffs on European goods, pose a risk to the company's operations and profitability.
Good afternoon, everyone and welcome to follow DT fourth quarter results announcing. My name is Hannu Martola, President and CEO of Detection Technology; and I have the pleasure to introduce you to the DT fourth quarter results.
As we call it was a strong finish to a good year. So, we reached sales of EUR31.6 million. A slight increase 1% increase to last year record. Fourth quarter '23 and reached EBITA EUR5.2 million which is a clear increase into the year on year 4.6 and reached an of EBITA 16.3%.
So, where did this come from?
So, both on a year on year and quarter on quarter, we clearly improved and actually had a notable increase in cash flow. Industrial sales grew 4%. This is very much driven by legacy industrial, if I call it this way because the sales actually slightly declined in fourth quarter due to the very severe and price competition in China. Medical sales was down 5% or negative 5% but also medical actually stabilized from the third quarter decline.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
